Who is sponsoring NCT01190891?

NCT01190891 is sponsored by Madigan Army Medical Center.

What condition does NCT01190891 study?

NCT01190891 studies Shoulder Impingement Syndrome.

What drugs are being tested in NCT01190891?

Interventions: Manual Physical Therapy, Corticosteroid Injection.

What is the status of NCT01190891?

NCT01190891 is currently COMPLETED.

Last reviewed 2016-03-28 · How we verify

A Manual Physical Therapy Approach Versus Subacromial Corticosteroid Injection for Treatment of Shoulder Impingement Syndrome: a Randomized Clinical Trial

NCT01190891 NA COMPLETED Results posted

The purpose of this study is to evaluate and compare the short and long-term effectiveness of two common interventions, manual physical therapy versus corticosteroid injection, for the treatment of shoulder impingement syndrome.

Details

Lead sponsor	Madigan Army Medical Center
Phase	NA
Status	COMPLETED
Enrolment	104
Start date	2010-05
Completion	2013-08

Conditions

Shoulder Impingement Syndrome

Interventions

Manual Physical Therapy
Corticosteroid Injection

Primary outcomes

Shoulder Pain and Disability Index — 1 year
The SPADI is a 100-point, 13 item self-administered questionnaire divided into two subscales (pain and disability), with higher scores indicating greater pain and disability. It is responsive to change and accurately discriminates between patients who are improving or worsening. It has high test-retest reliability and internal consistency. The minimal detectable change (MDC) is 18 and the minimally clinically important difference (MCID) is between 8-13 points. The validity and responsiveness to change of SPADI have been described in physical therapy, as well as primary and secondary care settings.

Countries

United States